Recent Posts

Supply chain chaos, surging costs set to plague Europe’s Q3 profits

Bloomberg Cost pressures, supply-chain chaos and a reopening letdown are set to plague Europe’s third-quarter earnings season, setting investors up for more disappointment than elation. While strong numbers from behemoths like LVMH and SAP SE reassured European stock investors last week, further good news may be needed to keep the rally alive. Rising inflation and a stalling global recovery pose ...

Read More »

Instagram frets about engaging teenagers

Bloomberg The photo-sharing app Instagram spent time focusing on how to retain and engage teenagers, New York Times reported, citing internal documents. Facebook Inc-owned Instagram was privately worried potentially losing teenage users to other social-media platforms, calling it an “existential threat,” according to a marketing presentation for 2018, the year it reached one billion users, the paper reported . Separately, ...

Read More »

AstraZeneca wins ruling on key patent for diabetes drug

Bloomberg AstraZeneca Plc won a federal court ruling upholding a key patent for its diabetes drug Farxiga, staving off threats from cheaper versions. A trial without a jury in May centered on the validity of a patent that covers Farxiga’s active ingredient, dapagliflozin, its combination with a carrier and methods of treatment. Zydus Cadila conceded infringement before the trial, a ...

Read More »
Send this to a friend